News

The Phase II dose-finding study is designed to further evaluate the ability of BA058 to build new bone for the treatment of osteoporosis in postmenopausal women. The randomized,

According to the study, patients who never received drug samples had $178 estimated out-of-pocket prescription costs over six months, while those receiving samples spent an estimated $166 for

According to the survey, 92% of respondents rated global cost reduction as a key issue, while 56% felt it was the role of CFOs to lead cost reduction

According to the data from Insight Health, for 92% of the 84,000 pharmaceutical products available, prices will be the same as last month, while 4.4% of them will

As part of the appeal process, Labopharm has requested a meeting with Janet Woodcock, the FDA’s director, Center for Drug Evaluation and Research. The Agency usually grants such

Advanced Medical Optics (AMO) claims that its advanced formula for blink Tears lubricating eye drops includes a blend of ingredients naturally found in the eye. The product is

These findings suggest the value of Haptoglobin testing in people with diabetes in order to ensure more successful treatment in the prevention of cardiovascular events (such as heart

Protectan CBLB502 was administered as a single injection at 48 hours post-exposure to 6.5 Gy doses of ionizing radiation, which results in approximately 75% mortality, if untreated (similar

The investment is an extension of the previously announced C round and will allow CoAxia to continue its Sentis pivotal FDA trial of NeuroFlo Perfusion Augmentation Therapy in